Home › Essential Thrombocythemia › Missouri › Kansas City
Essential Thrombocythemia clinical trials in Kansas City, MO
3 studies for Essential Thrombocythemia are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- The University of Kansas Cancer Center, Westwood · 5 mi away
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- The University of Kansas Cancer Center, Westwood · 5 mi away
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Chicago, IL4 studies
- Mountain View, CA4 studies
- Baltimore, MD4 studies
- Nashville, TN4 studies
- Boston, MA4 studies
- Miami, FL4 studies
- Salt Lake City, UT4 studies
- Irvine, CA3 studies
- Los Angeles, CA3 studies
- St. Louis, MO3 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer31 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer19 studies
- Colorectal Cancer16 studies
- Metastatic Cancer15 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer14 studies
- Ovarian Cancer11 studies
- Obesity11 studies
- Type 2 Diabetes11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.